NCT07370610

Brief Summary

Acute Respiratory Distress Syndrome (ARDS) is characterized by severe hypoxemia and extensive lung injury. Recent studies indicate that lung functional phenotypes - particularly the distribution and evolution of lung perfusion - may be closely related to patient outcomes. Electrical impedance tomography (EIT) offers non-invasive, bedside, real-time monitoring of lung perfusion patterns and enables classification into distinct phenotypes and trajectory types over the course of illness. To date, limited data exist on perfusion phenotype trajectories in ARDS patients and their relationship with clinical outcomes. This study seeks to characterize dynamic lung dynamic ventilation-perfusion functional Phenotype using EIT and explore their prognostic significance. Objectives Primary Objective: To identify lung perfusion phenotype trajectories in ARDS patients using EIT and assess their association with 28-day mortality. Secondary Objectives:

  • To determine the relationship between different trajectory types and improvements in oxygenation and respiratory mechanics.
  • To investigate how ventilator settings (PEEP, driving pressure) interact with perfusion changes.
  • To support individualized mechanical ventilation strategies based on Ventilation-Perfusion Functional Phenotype monitoring

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
6mo left

Started Jan 2025

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress73%
Jan 2025Jan 2027

Study Start

First participant enrolled

January 1, 2025

Completed
1 year until next milestone

First Submitted

Initial submission to the registry

January 19, 2026

Completed
8 days until next milestone

First Posted

Study publicly available on registry

January 27, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2026

Expected
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2027

Last Updated

April 13, 2026

Status Verified

January 1, 2026

Enrollment Period

2 years

First QC Date

January 19, 2026

Last Update Submit

April 9, 2026

Conditions

Keywords

eitlung perfusion patternsAcute Respiratory Distress Syndrome

Outcome Measures

Primary Outcomes (1)

  • 28-day all-cause mortality

    From enrollment to 28 days

Secondary Outcomes (4)

  • Time to oxygenation improvement (PaO₂/FiO₂ > 200 mmHg)

    From enrollment until the event occurs, assessed up to 14 days

  • Duration of mechanical ventilation

    From intubation until successful extubation, assessed up to 28 days or until ICU discharge/death

  • ICU length of stay

    From ICU admission until discharge from ICU, assessed up to 60 days

  • Interaction between phenotype trajectory and ventilator settings (PEEP, driving pressure)

    Daily during EIT monitoring period, up to 14 days

Study Arms (1)

EIT Monitoring group

* 16-electrode belt positioned around the thorax * Daily perfusion assessment (10 min recording) at baseline and after major clinical interventions (e.g., PEEP change, position change) * Pulmonary perfusion analysis will primarily be based on the pulse-synchronous impedance signal derived from EIT during brief respiratory pauses, estimating regional perfusion from cardiac-related impedance changes. When signal quality is insufficient, or in cases of significant arrhythmia or other conditions affecting pulse signal detection, the saline indicator method will be applied for validation or calibration. * This involves rapid intravenous bolus injection of 10-20 mL room-temperature saline, using the induced transient conductivity change as a perfusion marker:Ventilation-Perfusion Functional Phenotype will be derived by combining EIT-based tidal and pulsatile impedance changes, calculating the regional V/Q ratio.

Device: EIT Monitoring

Interventions

* 16-electrode belt positioned around the thorax * Daily perfusion assessment (10 min recording) at baseline and after major clinical interventions (e.g., PEEP change, position change) * Pulmonary perfusion analysis will primarily be based on the pulse-synchronous impedance signal derived from EIT during brief respiratory pauses, estimating regional perfusion from cardiac-related impedance changes. When signal quality is insufficient, or in cases of significant arrhythmia or other conditions affecting pulse signal detection, the saline indicator method will be applied for validation or calibration. * This involves rapid intravenous bolus injection of 10-20 mL room-temperature saline, using the induced transient conductivity change as a perfusion marker:Ventilation-Perfusion Functional Phenotype will be derived by combining EIT-based tidal and pulsatile impedance changes, calculating the regional V/Q ratio.

EIT Monitoring group

Eligibility Criteria

Age18 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

ARDS Mechanically Ventilated Patients

You may qualify if:

  • ge ≥ 18 years
  • Moderate-to-severe ARDS (Berlin definition, PaO₂/FiO₂ ≤ 200 mmHg)
  • Mechanically ventilated and eligible for EIT monitoring
  • Informed consent obtained from patient or legal surrogate

You may not qualify if:

  • Pregnancy
  • Presence of implanted metallic devices interfering with EIT (e.g., pacemaker)
  • Severe chest wall deformity or skin condition preventing electrode placement
  • Expected survival \< 24 hours

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

Shanghai, Shanghai Municipality, 200025, China

Location

MeSH Terms

Conditions

Respiratory Distress Syndrome

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesRespiration Disorders

Study Officials

  • Hongping Qu

    Department of Critical Care Medicine,Ruijin Hospital,Shanghai Jiao Tong University School of Medicine

    STUDY CHAIR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
28 Days
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 19, 2026

First Posted

January 27, 2026

Study Start

January 1, 2025

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

January 1, 2027

Last Updated

April 13, 2026

Record last verified: 2026-01

Locations